bionomics-rgb-1024px.png
Bionomics Announces Accepted Abstract and Upcoming Poster Presentations at the American College of Neuropsychopharmacology (ACNP) 2022 Annual Meeting
02 déc. 2022 06h00 HE | Bionomics Ltd
ADELAIDE, Australia, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
New Logo July 12, 2022.png
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
23 nov. 2022 08h30 HE | Odyssey Health, Inc
Las Vegas, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...
bionomics-rgb-1024px.png
Bionomics Limited Announces Closing of US$5 Million Underwritten Offering of American Depositary Shares in the United States
21 nov. 2022 18h13 HE | Bionomics Ltd
ADELAIDE, Australia, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, Nasdaq: BNOX), (“Bionomics” or the “Company”), a clinical-stage biopharmaceutical company developing novel,...
bionomics-rgb-1024px.png
Bionomics Limited Announces Pricing of Underwritten Offering of American Depositary Shares in the United States
16 nov. 2022 18h36 HE | Bionomics Ltd
ADELAIDE, Australia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, Nasdaq: BNOX), (“Bionomics” or the “Company”), a clinical-stage biopharmaceutical company developing novel,...
New Logo July 12, 2022.png
Odyssey Health, Inc. Schedules Annual Meeting of Stockholders
15 nov. 2022 08h00 HE | Odyssey Health, Inc
Las Vegas, Nevada, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on...
CCM Logo.jpg
Veterans Increasingly Seek Alternative Therapies to Manage PTSD, Depression and Other Challenges of Civilian Life
10 nov. 2022 14h06 HE | Cannabis Creative Movement
DENVER, Nov. 10, 2022 (GLOBE NEWSWIRE) -- U.S. Veterans are increasingly investigating complementary or alternative treatment options like yoga, exercise, acupuncture, meditation and cannabis to...
The Headstrong Project, Inc., Receives Second Investment from The A. James & Alice B. Clark Foundation
10 nov. 2022 08h00 HE | The Headstrong Project
New York, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Headstrong Project Inc., a national-facing mental health treatment practice of choice providing military connected individuals and their families with...
Lieutenant-General (retired) J.O. Michel Maisonneuve to lead fundraising efforts supporting research and treatment for Veterans experiencing chronic pain HAMILTON, Ontario, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Chronic Pain Centre of Excellence for Canadian Veterans (CPCoE) is excited to announce it has appointed Lieutenant-General (retired) J.O....
Le lieutenant-général (ret) J.O. Michel Maisonneuve dirigera la campagne de financement à l’appui de la recherche et des traitements pour les vétérans vivant avec la douleur chronique HAMILTON, Ontario, 10 nov. 2022 (GLOBE NEWSWIRE) -- Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens (CESLDC) est heureux d’annoncer la nomination du lieutenant-général...
New Logo July 12, 2022.png
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
03 nov. 2022 08h30 HE | Odyssey Health, Inc
Las Vegas, Nevada, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on...